LLT change status of patients with definite or probable FH at 6-month of follow-up.
Discontinued defined as any LLT prescription at index date but no LLT prescription at 6-month of follow-up. Switching defined as different LLT/combination of LLT prescribed during follow-up than the LLT prescribed at index date. Increase defined as one or more new LLT started during follow-up with index drugs also still continued. Decrease defined as one or more LLT at index date no longer taken at follow-up, but one or more LLT at index date still continued. No change defined as no change in LLT drugs prescribed between index date and follow-up.
Verfasser: | |
---|---|
Dokumenttyp: | Image |
Erscheinungsdatum: | 2021 |
Schlagwörter: | Biochemistry / Medicine / Biotechnology / Cancer / Science Policy / Infectious Diseases / Virology / Computational Biology / Environmental Sciences not elsewhere classified / Chemical Sciences not elsewhere classified / 6- month / PCSK / French sample / cohort study Background / statin / Health Improvement Network / LLT / THIN / LDL-C goal / Untreated Familial Hypercholesterolemia / management / Results 116 patients / DLCN / follow-up / Dutch Lipid Clinic Network / FH patients |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-29019124 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1371/journal.pone.0255345.g003 |